ID   BK-10
AC   CVCL_S718
SY   BK 10; BK10
DR   SKY/M-FISH/CGH; 1465
DR   Wikidata; Q54797034
RX   PubMed=9719413;
RX   PubMed=10221340;
CC   Doubling time: 44.9 hours (Note=In PEC medium), 30.48 hours (Note=In F medium) (PubMed=9719413).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
RX   PubMed=9719413; DOI=10.1007/s11626-998-0113-y;
RA   Roberson, Kathryn M.
RA   Yancey, Donna R.
RA   Padilla-Nash, Hesed Maria
RA   Edwards, Darryl W.
RA   Nash, William G.
RA   Jacobs, Sharone
RA   Padilla, George M.
RA   Larchian, William Aram
RA   Robertson, Cary Nobles
RT   "Isolation and characterization of a novel human bladder cancer cell
RT   line: BK10.";
RL   In Vitro Cell. Dev. Biol. Anim. 34:537-544(1998).
//
RX   PubMed=10221340; DOI=10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T;
RA   Padilla-Nash, Hesed Maria
RA   Nash, William G.
RA   Padilla, George M.
RA   Roberson, Kathryn M.
RA   Robertson, Cary Nobles
RA   Macville, Merryn V.E.
RA   Schrock, Evelin
RA   Ried, Thomas
RT   "Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10
RT   by spectral karyotyping.";
RL   Genes Chromosomes Cancer 25:53-59(1999).
//